Cargando…
Immunotherapy: rAAV2 expressing interleukin-15 inhibits HeLa cell tumor growth in mice
Human interleukin-15 (hIL15) has anti-tumor activities, but it is not convenient for tumor treatment because of its short half-life. A gene therapy for mouse lung cancer using an adenovirus vector expressing IL15 has been reported. However, adenovirus vector-mediated gene therapy can provoke cellula...
Autores principales: | Yiang, Giou-Teng, Harn, Horng-Jyh, Yu, Yung-Luen, Hu, Sheng-Chuan, Hung, Yu-Ting, Hsieh, Chia-Jung, Lin, Shinn-Zong, Wei, Chyou-Wei |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2687432/ https://www.ncbi.nlm.nih.gov/pubmed/19422685 http://dx.doi.org/10.1186/1423-0127-16-47 |
Ejemplares similares
-
Anti-Cancer Effects of Sulfasalazine and Vitamin E Succinate in MDA-MB 231 Triple-Negative Breast Cancer Cells
por: Wei, Chyou-Wei, et al.
Publicado: (2019) -
Vitamin C enhances anticancer activity in methotrexate-treated Hep3B hepatocellular carcinoma cells
por: YIANG, GIOU-TENG, et al.
Publicado: (2014) -
Robust Long-term Transduction of Common Marmoset Neuromuscular Tissue With rAAV1 and rAAV9
por: Okada, Hironori, et al.
Publicado: (2013) -
rAAV-delivered PTEN therapeutics for prostate cancer
por: Ai, Jianzhong, et al.
Publicado: (2021) -
Anti-cancer therapeutic benefit of red guava extracts as a potential therapy in combination with doxorubicin or targeted therapy for triple-negative breast cancer cells
por: Liu, Hsiao-Chun, et al.
Publicado: (2020)